Cargando…
Efficacy and safety of ucha-shinki-hwan on korean patients with cold hypersensitivity in the hands and feet: Study protocol clinical trial (SPIRIT Compliant)
BACKGROUND: Cold hypersensitivity in the hands and feet (CHHF) is a common complaint in Asian female population especially in Korea. Due to the symptoms of CHHF the quality of individual's daily life can be degraded. Ucha-Shinki-Hwan (UCHA) is widely used in the treatment of various diseases in...
Autores principales: | Ko, Youme, Sun, Seung-Ho, Go, Ho-Yeon, Lee, Jin-Moo, Jang, Jun-Bok, Sung, Hyun-Kyung, Jang, Bo-Hyoung, Jeon, Chan-Yong, Ko, Seong-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034626/ https://www.ncbi.nlm.nih.gov/pubmed/32080084 http://dx.doi.org/10.1097/MD.0000000000019110 |
Ejemplares similares
-
Acupuncture as an adjuvant therapy for management of treatment-related symptoms in breast cancer patients: Systematic review and meta-analysis (PRISMA-compliant)
por: Jang, Soobin, et al.
Publicado: (2020) -
A pilot study exploring the efficacy and safety of herbal medicine on Korean obese women with metabolic syndrome risk factors: Double blinded, randomized, multicenter, placebo controlled study protocol clinical trial
por: Kim, Hyun-ju, et al.
Publicado: (2020) -
Efficacy and safety of Ojeok-san in Korean female patients with cold hypersensitivity in the hands and feet: study protocol for a randomized, double-blinded, placebo-controlled, multicenter pilot study
por: Ko, Youme, et al.
Publicado: (2018) -
The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial
por: Ko, Youme, et al.
Publicado: (2019) -
Elucidating the potential pharmaceutical mechanism of Gyejibokryeong-hwan on rosacea using network analysis
por: Kim, Jundong, et al.
Publicado: (2023)